Chippenham Hospital

The trials here

What the 9 trials at this site are about, from their registry records.

Conditions

• Atrial fibrillation3 trials
• Coronary artery disease3 trials
• Heart failure2 trials
• Stroke2 trials
• Familial hypercholesterolaemia1 trial
• High blood pressure1 trial
• Ventricular tachycardia1 trial

Phase

• Phase 43 trials

Status

• Active, not recruiting4 trials
• Completed2 trials
• Recruiting2 trials
• Suspended1 trial

Lead sponsor

• Abbott Medical Devices1 trial
• Amgen1 trial
• Cedars-Sinai Medical Center1 trial
• Conformal Medical, Inc1 trial
• Duke University1 trial
• and 4 more

Running trials

• Recruiting

  Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention

  NCT06909565· Phase 4· Duke University· Source

  Contact: Casey Garrett

• Recruiting

  THRIVE- THerapeutic IntravasculaR Ultrasound (TIVUS™) REnal Denervation System Versus Sham for the Adjunctive Treatment of Hypertension

  NCT06559891· SoniVie Inc.· Source

  Contact: Nayef Abouzaki, MD

• Active, not recruiting

  Assessment of Combined CCM and ICD Device in HFrEF

  NCT05855135· Impulse Dynamics· Source

• Active, not recruiting

  EVOLVE-MI: EVOLocumab Very Early After Myocardial Infarction

  NCT05284747· Phase 4· Amgen· Source

• Active, not recruiting

  Abbott Atrial Fibrillation Post Approval Study

  NCT05434650· Abbott Medical Devices· Source

• Active, not recruiting

  Women's IschemiA TRial to Reduce Events In Non-ObstRuctive CAD

  NCT03417388· Phase 4· Cedars-Sinai Medical Center· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Coronary artery disease1 recruiting
• Familial hypercholesterolaemia1 recruiting
• High blood pressure1 recruiting

Closed trials

• Completed

  Concomitant LAAC/AF Ablation (Watchman FLX Pro)

  NCT07041125· Heart Rhythm Clinical and Research Solutions, LLC· Source

• Completed

  Benefits of µCor in Ambulatory Decompensated Heart Failure

  NCT03476187· Zoll Medical Corporation· Source